Many studies have found that lung cancer cells with a high expression of the CD44 subset have higher tumorigenic ability, tumor sphere formation ability, and migration characteristics than those with low expressions of CD44 [35,36,37,38]. The gene discussed is CD44; the disease is lung carcinoma.